scholarly journals Transcatheter Tricuspid Valve-in-Valve Procedure—An Illustrative Case Report and Review

2021 ◽  
Vol 10 (17) ◽  
pp. 4004
Author(s):  
Márcio José Montenegro da Costa ◽  
Edgard Freitas Quintella ◽  
Luiz Kohn ◽  
Maximiliano Otero Lacoste ◽  
Gustavo Lycurgo Leite ◽  
...  

Severe tricuspid commitment is no longer understood as merely a marker of disease but is now widely thought of as a significant contributor to cardiac morbidity and mortality. However, isolated tricuspid valve surgery remains rare and to this day continues to be associated with the highest surgical risk among all valve procedures and high operative mortality rates, especially in reoperations. Therefore, the development of tricuspid transcatheter procedures is as necessary as it was for the other valves a couple of years ago. Recently, multiple percutaneous therapies have been developed for the management of severe tricuspid disease, initially only repair and more recently replacement, thus creating a new branch for the management of patients who have already undergone surgery and who present with dysfunctional bioprostheses. The purpose of this review and report is to demonstrate current and possible future challenges, and to show that the valve-in-valve procedure of the tricuspid valve is feasible and safe, and now can be performed in all its range, in the smallest to the largest sizes of presentation, without incurring the untoward risks of conventional surgery.

Author(s):  
Arman Kilic ◽  
Wilson Y. Szeto ◽  
Pavan Atluri ◽  
Michael A. Acker ◽  
W. Clark Hargrove

Objective The aim of this study was to evaluate whether the addition of concomitant tricuspid valve surgery (TVS) negatively impacted operative outcomes of minimally invasive mitral valve surgery (MIMVS). Methods Patients undergoing MIMVS via a port-access right minithoracotomy between 2002 and 2014 at a single institution were reviewed. Patients were primarily stratified by those undergoing isolated MIMVS versus MIMVS+TVS. Propensity-matched cohorts were generated. Operative outcomes were compared between the propensity-matched cohorts and included operative mortality, complications, and length of hospital stay. Results A total of 1,158 patients underwent MIMVS via port-access right minithoracotomy. The majority of cases were elective (93%; n = 1,071) and 148 (13%) underwent concomitant MIMVS + TVS. Patients undergoing MIMVS + TVS were at higher risk at baseline. After propensity-matching, there were 119 isolated MIMVS and 119 MIMVS + TVS patients that were well matched with respect to all baseline variables. Cardiopulmonary bypass (148 ± 54 minutes versus 175 ± 54 minutes, P < 0.001) and aortic occlusion times (105 ± 36 minutes versus 128 ± 40 minutes, P < 0.001) were longer in the MIMVS + TVS group. Operative mortality was comparable (3% isolated MIMVS versus 4% for MIMVS + TVS; P = 0.73). Permanent pacemakers were required less frequently in the isolated MIMVS group (1% versus 6%; P = 0.03). All other complication rates were similar. Median length of hospital stay (7 versus 8 days; P = 0.13) and discharge-to-home rates (89% versus 94%; P = 0.15) were comparable. Conclusions Despite longer operative times, minimally invasive TVS performed concomitantly with MIMVS has similar operative outcomes with the exception of a higher pacemaker rate when compared with isolated MIMVS.


2018 ◽  
pp. 149-153
Author(s):  
Z H Teoh ◽  
J Roy ◽  
J Reiken ◽  
M Papitsas ◽  
J Byrne ◽  
...  

Moderate-to-severe tricuspid regurgitation is associated with higher mortality and morbidity yet remains significantly undertreated. The reasons for this are complex but include a higher operative mortality for patients undergoing isolated tricuspid valve surgery. This study sought to determine the prevalence of patients with moderate-to-severe tricuspid regurgitation and identify those who could be potentially suitable for percutaneous tricuspid valve intervention by screening patients referred for transthoracic echocardiography (ECHO) at a tertiary center. Our results showed that the prevalence of moderate-to-severe tricuspid regurgitation in our total ECHO patient population was 2.8%. Of these, approximately one in eight patients with moderate-to-severe tricuspid regurgitation would be potentially suitable for percutaneous intervention and suggests a large, unmet clinical need in this population.


2014 ◽  
Vol 62 (S 01) ◽  
Author(s):  
K.-W. Felkel ◽  
K. Kampmann ◽  
F. Hahnel ◽  
H. Reichenspurner ◽  
H. Gulbins

2018 ◽  
Vol 66 (6) ◽  
Author(s):  
Ahmed El-Eshmawi ◽  
Dimosthenis Pandis ◽  
David H. Adams ◽  
Gilbert H. Tang

2021 ◽  
Vol 5 (sup1) ◽  
pp. 10-10
Author(s):  
Sri Harsha Patlolla ◽  
Hartzell V. Schaff ◽  
Juan A. Crestanello ◽  
Joseph A. Dearani ◽  
Richard C. Daly ◽  
...  

2021 ◽  
Vol 36 (3) ◽  
pp. 981-989 ◽  
Author(s):  
Lauren Huckaby ◽  
Laura Seese ◽  
Yeahwa Hong ◽  
Ibrahim Sultan ◽  
Thomas Gleason ◽  
...  

2021 ◽  
Vol 77 (18) ◽  
pp. 1247
Author(s):  
Amy Hembree ◽  
Matthew Lawlor ◽  
Samantha Nemeth ◽  
Andrea Miltiades ◽  
Paul Kurlansky ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document